9
项与 Anti-CD19 CAR-T (The Affiliated Hospital of Xuzhou Medical University) 相关的临床试验Prospective, Multicenter, Open, One-arm Clinical Study of the Safety and Efficacy of the R/R B-NHL Regimen With BTK Inhibitor+Anti-CD19 CAR-T Cells
To evaluate the ORR (CR+PR) of R/R B-NHL subjects treated with BTKi+Anti-CD19 CAR T cells.
Prospective, Multicenter, Open, One-arm Clinical Study of Safety and Efficacy of Autologous Stem Cell Transplantation + Anti-CD19 CAR T Cells for B-cell Lymphoma
To evaluate the CR rate of B-NHL subjects who achieved PR at intermediate assessment after first-line chemotherapy treated with autologous stem cell transplantation + Anti-CD19 CAR T cells.
Combination of humanized anti-CD19 CAR-T and anti-BCMA CAR-T versus autogolous hematopoietic stem cell transplantation for non-complete remission multiple myeloma: a single center, open-label, randomized controlled trial
100 项与 Anti-CD19 CAR-T (The Affiliated Hospital of Xuzhou Medical University) 相关的临床结果
100 项与 Anti-CD19 CAR-T (The Affiliated Hospital of Xuzhou Medical University) 相关的转化医学
100 项与 Anti-CD19 CAR-T (The Affiliated Hospital of Xuzhou Medical University) 相关的专利(医药)
100 项与 Anti-CD19 CAR-T (The Affiliated Hospital of Xuzhou Medical University) 相关的药物交易